Combination Pravastatin and Valsartan Treatment Has Additive Beneficial Effects to Simultaneously Improve Both Metabolic and Cardiovascular Phenotypes Beyond That of Monotherapy With Either Drug in Patients With Primary Hypercholesterolemia

Statin and angiotensin II type 1 receptor blocker therapy improves endothelial dysfunction using distinct mechanisms. We evaluated simultaneous vascular and metabolic responses to pravastatin and valsartan therapy, alone or in combination, in hypercholesterolemic patients. Forty-eight hypercholester...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Koh, Kwang Kon, Lim, Soo, Choi, Hanul, Lee, Yonghee, Han, Seung Hwan, Lee, Kyounghoon, Oh, Pyung Chun, Sakuma, Ichiro, Shin, Eak Kyun, Quon, Michael J.
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2013
Matèries:
Pathophysiology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3781478/
https://ncbi.nlm.nih.gov/pubmed/23863812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db13-0566
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars